featured
Outcomes of Intravitreal Triple Therapy With Vancomycin, Ceftazidime, and Moxifloxacin for Bacterial Endophthalmitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Graefe's Archive for Clinical and Experimental Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intravitreal triple therapy with vancomycin, ceftazidime, and moxifloxacin for bacterial endophthalmitis: A Twelve-year experience
Graefes Arch. Clin. Exp. Ophthalmol 2023 Oct 01;261(10)2813-2819, KJ Taubenslag, EF Cherney, SN Patel, JC Law, AB Daniels, SJ KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.